Author

M. M. Gottardis

Observed names: M M Gottardis, M.M. Gottardis, MM Gottardis

Institutions: Mayo Clinic, The University of Texas MD Anderson Cancer Center, Bristol-Myers Squibb (United States)

Observed institutions: Mayo Clinic, The University of Texas MD Anderson Cancer Center, University of Wisconsin–Madison, Universitätsklinikum Gießen und Marburg, Georgetown University Medical Center, Bristol-Myers Squibb (United States), University of Wisconsin Carbone Cancer Center, Ligand Pharmaceuticals (United States), Georgetown Lombardi Comprehensive Cancer Center

OpenAlex ID: A5070469372

Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells

1996 · G Zugmaier, R Jäger, et al. · British Journal of Cancer · 89

Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.

1995 · D R Shalinsky, E D Bischoff, et al. · PubMed · 48

Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells

1996 · SW McLeskey, L Zhang, et al. · British Journal of Cancer · 41

Phase II trial of the dual IGF-1R/IR inhibitor BMS-754807 with or without letrozole in aromatase inhibitor-resistant breast cancer.

2011 · P. Haluska, A. Dhar, et al. · Journal of Clinical Oncology · 12

Drug efflux by breast cancer resistance protein (BCRP) is a mechanism of resistance to the insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924.

2009 · P Haluska, JM Carboni, et al. · Cancer Research · 3

P2-11-11: IGFBP Ratio Confers Resistance to IGF Targeting and Correlates with Increased Invasion and Poor Outcome in Breast Tumors.

2011 · MA Becker, X Hou, et al. · Cancer Research · 2

Effect of dual inhibition of the Src and insulin-like growth factor-1 receptor (IGF-1R) pathways on antitumor effects in prostate cancer (PCa).

2011 · F. Dayyani, N. Parikh, et al. · Journal of Clinical Oncology · 2

HER receptor signaling confers resistance to IGF-1R targeted therapy

2008 · P. Haluska, J. M. Carboni, et al. · Journal of Clinical Oncology · 1

Antitumor effects of dual inhibition of the Src and insulin-like growth factor-1 receptor (IGF-1R) pathways in prostate cancer (PCa).

2011 · F. Dayyani, N. Parikh, et al. · Journal of Clinical Oncology

P-01 HER receptor signaling confers resistance to the insulin-like growth factor 1 receptor inhibitor, BMS-536924

2008 · P. Haluska, J.M. Carboni, et al. · Growth Hormone & IGF Research

Long-term tamoxifen therapy of athymic mice implanted with MCF-7 tumors: Tumoristatic action and antiestrogenic action in the moose uterus

1987 · V.C. Jordan, M.M. Gottardis · Journal of Steroid Biochemistry

Works count: 11

Citation count: 198

H-index: 4

I10-index: 4